The Enferplex Bovine TB test has been approved by OIE in June 2019, the World Health Organisation for animal health, for the following uses:
To detect antibodies to Mycobacterium bovis (M. bovis), and other mycobacteria belonging to the Mycobacterium tuberculosis complex, in serum from cattle, to be used as a supplemental test in conjunction with other methods for diagnosing and managing M. bovis infection. In particular, the test can be used for the following specific purposes:
To confirm, but not negate, diagnosis of suspect or clinical cases, including confirmation of positive screening tests in individual animals and in herds with infection prevalence ranging from very low to high.
To detect M. bovis infected animals not positive by Single Intradermal Comparative Cervical Tuberculin or Interferon Gamma tests.
To confirm, but not negate, infection in animals giving inconclusive reactions in the SICCT.
To identify animals most likely to have visible lesions (VL) by scoring the number of M. bovis antigens recognised by seropositive Bovine TB-infected animals.
We are currently in discussion with the UK and Irish Governments as to how the test may be used for the detection and control of bovine TB.
For the time being the use of the test is still be restricted by the UK Government to herds under Tb restriction where the gamma-interferon test has been used. We hope that these restrictions will be lifted soon.